Data News > Amazon Enters Pet Medication Market, H Partners Exposes Harley-Davidson Board, and More Financial News
- Amazon partners with Vetsource to sell pet medications
- H Partners exposes commitments made by Harley-Davidson's Board
- Alaris Equity Partners releases financial results
- Primo Brands announces secondary offering of shares
- Rocket Lab partners with U.S. Air Force for Neutron launch
Amazon announced a new partnership with pet pharmacy Vetsource to begin selling prescription pet medications. This move will significantly expand Amazon's platform to include hundreds of prescription medications for pets. In other news, H Partners Management, LLC, a major shareholder of Harley-Davidson, Inc., revealed secret, undisclosed commitments made by the company's Board of Directors. This news comes ahead of the upcoming Annual Meeting of Shareholders.
Alaris Equity Partners Income Trust recently released its 2025 first quarter financial results. Meanwhile, Primo Brands Corporation announced a secondary offering of 47,500,000 shares of Class A Common Stock by affiliates of One Rock Capital Partners. In the space sector, Rocket Lab USA, Inc. disclosed a partnership with the U.S. Air Force for a Neutron launch, marking a new era in commercial launch capability for global defense logistics.
Generational Capital Markets facilitated the sale of Clearwater Engineering, Inc. to Precision Aerospace Holdings, LLC, a portfolio company of Juniper Capital Management and CIC Partners. Cheniere Energy Partners, L.P. reported its first quarter earnings and key metrics, providing insights into its performance compared to estimates.
OMS360 announced a partnership with Pittsburgh Oral Surgery and secured financing from TPG Twin Brook for continued growth. Suburban Propane Partners, L.P. shared its second-quarter results, while Kimbell Royalty Partners reported record first-quarter results. Kimbell's financial highlights included increased revenues, net income, EBITDA, and cash available for distribution, reflecting a robust start to 2025.
Esperion Therapeutics partnered with HLS Therapeutics to commercialize NEXLETOL® and NEXLIZET® in Canada, expanding access to preventative therapy for millions of Canadians living with diagnosed heart disease. Partners Group selected Northern Trust to support its Private Credit-Focused Long Term Asset Fund (LTAF), enhancing its fund administration, depositary, and banking services for their first LTAF launched in April 2025.
For more information:
Up/Down Rally Price Distribution Analyst Recommendations Earning Price Impact Analysis Seasonality
For more information:
Earning Price Impact Earning Estimates Earning Call Transcript
Amazon Enters Pet Medication Market, H Partners Exposes Harley-Davidson Board, and More Financial News
By KlickAnalytics Data Insights | May 8, 2025 08:00PM ET
Key Points
- Amazon partners with Vetsource to sell pet medications
- H Partners exposes commitments made by Harley-Davidson's Board
- Alaris Equity Partners releases financial results
- Primo Brands announces secondary offering of shares
- Rocket Lab partners with U.S. Air Force for Neutron launch
Amazon announced a new partnership with pet pharmacy Vetsource to begin selling prescription pet medications. This move will significantly expand Amazon's platform to include hundreds of prescription medications for pets. In other news, H Partners Management, LLC, a major shareholder of Harley-Davidson, Inc., revealed secret, undisclosed commitments made by the company's Board of Directors. This news comes ahead of the upcoming Annual Meeting of Shareholders.
Alaris Equity Partners Income Trust recently released its 2025 first quarter financial results. Meanwhile, Primo Brands Corporation announced a secondary offering of 47,500,000 shares of Class A Common Stock by affiliates of One Rock Capital Partners. In the space sector, Rocket Lab USA, Inc. disclosed a partnership with the U.S. Air Force for a Neutron launch, marking a new era in commercial launch capability for global defense logistics.
Generational Capital Markets facilitated the sale of Clearwater Engineering, Inc. to Precision Aerospace Holdings, LLC, a portfolio company of Juniper Capital Management and CIC Partners. Cheniere Energy Partners, L.P. reported its first quarter earnings and key metrics, providing insights into its performance compared to estimates.
OMS360 announced a partnership with Pittsburgh Oral Surgery and secured financing from TPG Twin Brook for continued growth. Suburban Propane Partners, L.P. shared its second-quarter results, while Kimbell Royalty Partners reported record first-quarter results. Kimbell's financial highlights included increased revenues, net income, EBITDA, and cash available for distribution, reflecting a robust start to 2025.
Esperion Therapeutics partnered with HLS Therapeutics to commercialize NEXLETOL® and NEXLIZET® in Canada, expanding access to preventative therapy for millions of Canadians living with diagnosed heart disease. Partners Group selected Northern Trust to support its Private Credit-Focused Long Term Asset Fund (LTAF), enhancing its fund administration, depositary, and banking services for their first LTAF launched in April 2025.
For more information:
For more information:
To view full story, Upgrade to PRO plan!
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.